Related Experiment Video
Updated: Feb 14, 2026

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
Personalized prediction of drug efficacy for diabetes treatment via patient-level sequential modeling with neural
1Department of Systems Management Engineering, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Republic of Korea.
Abstract:
Patients with type 2 diabetes mellitus are generally under continuous long-term medical treatment based on anti-diabetic drugs to achieve the desired glucose level. Thus, each patient is associated with a sequence of multiple records for prescriptions and their efficacies. Sequential dependencies are embedded in these records as personal factors so that previous records affect the efficacy of the current prescription for each patient. In this study, we present a patient-level sequential modeling approach utilizing the sequential dependencies to render a personalized prediction of the prescription efficacy. The prediction models are implemented using recurrent neural networks that use the sequence of all the previous records as inputs to predict the prescription efficacy at the time the current prescription is provided for each patient. Through this approach, each patient's historical records are effectively incorporated into the prediction. The experimental results of both the regression and classification analyses on real-world data demonstrate improved prediction accuracy, particularly for those patients having multiple previous records.
More Related Videos
Related Concept Videos
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

